Annual EBITDA
-$84.92 M
-$23.70 M-38.70%
December 31, 2023
Summary
- As of February 12, 2025, CDNA annual EBITDA is -$84.92 million, with the most recent change of -$23.70 million (-38.70%) on December 31, 2023.
- During the last 3 years, CDNA annual EBITDA has fallen by -$76.75 million (-939.27%).
- CDNA annual EBITDA is now -16336.90% below its all-time high of $523.00 thousand, reached on December 31, 2014.
Performance
CDNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$5.60 M
-$6.53 M-704.42%
September 30, 2024
Summary
- As of February 12, 2025, CDNA quarterly EBITDA is -$5.60 million, with the most recent change of -$6.53 million (-704.42%) on September 30, 2024.
- Over the past year, CDNA quarterly EBITDA has increased by +$18.15 million (+76.41%).
- CDNA quarterly EBITDA is now -272.24% below its all-time high of $3.25 million, reached on December 31, 2017.
Performance
CDNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$38.60 M
+$18.15 M+31.98%
September 30, 2024
Summary
- As of February 12, 2025, CDNA TTM EBITDA is -$38.60 million, with the most recent change of +$18.15 million (+31.98%) on September 30, 2024.
- Over the past year, CDNA TTM EBITDA has increased by +$41.13 million (+51.59%).
- CDNA TTM EBITDA is now -7369.49% below its all-time high of $531.00 thousand, reached on September 30, 2014.
Performance
CDNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDNA EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -38.7% | +76.4% | +51.6% |
3 y3 years | -939.3% | +76.4% | +51.6% |
5 y5 years | -647.3% | +76.4% | +51.6% |
CDNA EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -376.0% | at low | -704.4% | +76.4% | -116.4% | +54.5% |
5 y | 5-year | -939.3% | at low | -416.7% | +76.4% | -3517.7% | +54.5% |
alltime | all time | <-9999.0% | at low | -272.2% | +76.4% | -7369.5% | +54.5% |
CareDx EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$5.60 M(-704.4%) | -$38.60 M(-32.0%) |
Jun 2024 | - | $927.00 K(-106.6%) | -$56.75 M(-28.6%) |
Mar 2024 | - | -$14.11 M(-28.8%) | -$79.47 M(-6.4%) |
Dec 2023 | -$84.92 M(+38.7%) | -$19.81 M(-16.6%) | -$84.92 M(+6.5%) |
Sep 2023 | - | -$23.75 M(+9.0%) | -$79.73 M(+15.6%) |
Jun 2023 | - | -$21.80 M(+11.4%) | -$68.99 M(+5.7%) |
Mar 2023 | - | -$19.56 M(+33.8%) | -$65.27 M(+6.6%) |
Dec 2022 | -$61.22 M(+243.2%) | -$14.62 M(+12.3%) | -$61.22 M(+4.5%) |
Sep 2022 | - | -$13.02 M(-28.0%) | -$58.60 M(+14.2%) |
Jun 2022 | - | -$18.07 M(+16.4%) | -$51.30 M(+46.0%) |
Mar 2022 | - | -$15.52 M(+29.3%) | -$35.13 M(+96.9%) |
Dec 2021 | -$17.84 M(+118.3%) | -$12.00 M(+110.3%) | -$17.84 M(+182.7%) |
Sep 2021 | - | -$5.71 M(+200.2%) | -$6.31 M(+491.4%) |
Jun 2021 | - | -$1.90 M(-207.5%) | -$1.07 M(-63.0%) |
Mar 2021 | - | $1.77 M(-475.6%) | -$2.88 M(-64.7%) |
Dec 2020 | -$8.17 M(-53.0%) | -$471.00 K(+1.5%) | -$8.17 M(-26.2%) |
Sep 2020 | - | -$464.00 K(-87.5%) | -$11.07 M(-26.0%) |
Jun 2020 | - | -$3.72 M(+5.6%) | -$14.96 M(-12.2%) |
Mar 2020 | - | -$3.52 M(+4.5%) | -$17.05 M(-2.0%) |
Dec 2019 | -$17.39 M(+53.0%) | -$3.37 M(-22.7%) | -$17.39 M(+6.8%) |
Sep 2019 | - | -$4.36 M(-24.8%) | -$16.27 M(+19.5%) |
Jun 2019 | - | -$5.80 M(+50.0%) | -$13.62 M(+21.9%) |
Mar 2019 | - | -$3.86 M(+71.2%) | -$11.17 M(-1.7%) |
Dec 2018 | -$11.36 M | -$2.26 M(+32.3%) | -$11.36 M(+94.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2018 | - | -$1.71 M(-49.1%) | -$5.85 M(-63.4%) |
Jun 2018 | - | -$3.35 M(-17.3%) | -$16.01 M(+10.5%) |
Mar 2018 | - | -$4.05 M(-224.6%) | -$14.49 M(-0.8%) |
Dec 2017 | -$14.61 M(-33.1%) | $3.25 M(-127.4%) | -$14.61 M(-20.3%) |
Sep 2017 | - | -$11.86 M(+547.1%) | -$18.32 M(+102.6%) |
Jun 2017 | - | -$1.83 M(-56.0%) | -$9.04 M(-46.1%) |
Mar 2017 | - | -$4.17 M(+810.0%) | -$16.78 M(-23.2%) |
Dec 2016 | -$21.85 M(+94.0%) | -$458.00 K(-82.3%) | -$21.84 M(-14.7%) |
Sep 2016 | - | -$2.58 M(-73.0%) | -$25.60 M(-1.7%) |
Jun 2016 | - | -$9.57 M(+3.8%) | -$26.04 M(+35.6%) |
Mar 2016 | - | -$9.22 M(+118.3%) | -$19.21 M(+70.5%) |
Dec 2015 | -$11.26 M(-2253.3%) | -$4.23 M(+39.9%) | -$11.26 M(+75.6%) |
Sep 2015 | - | -$3.02 M(+10.4%) | -$6.41 M(+104.0%) |
Jun 2015 | - | -$2.74 M(+113.8%) | -$3.14 M(+394.2%) |
Mar 2015 | - | -$1.28 M(-305.1%) | -$636.00 K(-221.6%) |
Dec 2014 | $523.00 K(-369.6%) | $624.00 K(+150.6%) | $523.00 K(-1.5%) |
Sep 2014 | - | $249.00 K(-208.7%) | $531.00 K(+608.0%) |
Jun 2014 | - | -$229.00 K(+89.3%) | $75.00 K(-64.6%) |
Mar 2014 | - | -$121.00 K(-119.1%) | $212.00 K(-209.3%) |
Dec 2013 | -$194.00 K(-84.7%) | $632.00 K(-405.3%) | -$194.00 K(-76.5%) |
Sep 2013 | - | -$207.00 K(+125.0%) | -$826.00 K(+33.4%) |
Jun 2013 | - | -$92.00 K(-82.5%) | -$619.00 K(+17.5%) |
Mar 2013 | - | -$527.00 K | -$527.00 K |
Dec 2012 | -$1.27 M | - | - |
FAQ
- What is CareDx annual EBITDA?
- What is the all time high annual EBITDA for CareDx?
- What is CareDx annual EBITDA year-on-year change?
- What is CareDx quarterly EBITDA?
- What is the all time high quarterly EBITDA for CareDx?
- What is CareDx quarterly EBITDA year-on-year change?
- What is CareDx TTM EBITDA?
- What is the all time high TTM EBITDA for CareDx?
- What is CareDx TTM EBITDA year-on-year change?
What is CareDx annual EBITDA?
The current annual EBITDA of CDNA is -$84.92 M
What is the all time high annual EBITDA for CareDx?
CareDx all-time high annual EBITDA is $523.00 K
What is CareDx annual EBITDA year-on-year change?
Over the past year, CDNA annual EBITDA has changed by -$23.70 M (-38.70%)
What is CareDx quarterly EBITDA?
The current quarterly EBITDA of CDNA is -$5.60 M
What is the all time high quarterly EBITDA for CareDx?
CareDx all-time high quarterly EBITDA is $3.25 M
What is CareDx quarterly EBITDA year-on-year change?
Over the past year, CDNA quarterly EBITDA has changed by +$18.15 M (+76.41%)
What is CareDx TTM EBITDA?
The current TTM EBITDA of CDNA is -$38.60 M
What is the all time high TTM EBITDA for CareDx?
CareDx all-time high TTM EBITDA is $531.00 K
What is CareDx TTM EBITDA year-on-year change?
Over the past year, CDNA TTM EBITDA has changed by +$41.13 M (+51.59%)